ProMIS Neurosciences
PMN
12 hedge funds and large institutions have $889K invested in ProMIS Neurosciences in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
8% more capital invested
Capital invested by funds: $824K → $889K (+$64.8K)
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
8% less funds holding
Funds holding: 13 → 12 (-1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$7.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10.2K |
| 2 |
JP Morgan Chase
New York
|
-$1.47K |
| 3 |
Morgan Stanley
New York
|
-$1.47K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$246 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFC
1
Northeast Financial Consultants
Westport,
Connecticut
| $473K | – | – | – |
|
|
IC
2
IEQ Capital
Foster City,
California
| $185K | – | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| $69.6K | +$7.74K | +63 | +12% |
|
|
CAM
4
Claret Asset Management
Montreal,
Quebec, Canada
| $59K | – | – | – |
|
|
FT
5
Fiduciary Trust
Boston,
Massachusetts
| $48K | – | – | – |
|
|
6
JP Morgan Chase
New York
| $25K | -$1.47K | -12 | -5% |
|
|
7
Morgan Stanley
New York
| $11.9K | -$1.47K | -12 | -11% |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | -$246 | -2 | -2% |
|
|
GCM
9
Gables Capital Management
Miami,
Florida
| $3.94K | – | – | – |
|
10
National Bank of Canada
Montreal,
Quebec, Canada
| $1.56K | – | – | – |
|
|
TWC
11
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $946 | – | – | – |
|
|
AWM
12
AllSquare Wealth Management
Albany,
New York
| $887 | – | – | – |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$10.2K | -94 | Closed |
|
PMN Hedge Fund Activity: Q1 2023 in Review
12 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q1 2023, worth a combined $889K — up 7.9% from $824K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PMN and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, adding an estimated $7.74K. The largest seller was UBS Group, exiting entirely with an estimated $10.2K sold.
- 12 institutional investors held ProMIS Neurosciences (PMN) as of Q1 2023, down from 13 in Q4 2022.
- Funds reported $889K of ProMIS Neurosciences stock for Q1 2023, up 7.9% quarter-over-quarter.
- 0 funds opened new ProMIS Neurosciences positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest ProMIS Neurosciences buyer in Q1 2023 was Bank of America, an estimated $7.74K added.
- The largest ProMIS Neurosciences seller in Q1 2023 was UBS Group, an estimated $10.2K sold.
Based on aggregated 13F filings for Q1 2023.